In India, the Russian-developed Corona Vaccine Sputnik V has been approved for emergency use. This is the third vaccine for the coronavirus to be approved after Kovshield (Serum Institute of India) and Kovaxin (Bharat Biotech).
The Sputnik V vaccine, developed by Moscow's Gamale National Research Institute of Epidemiology and Microbiology, uses two different viruses that cause the common cold (adenovirus) in humans. Adenovirus becomes weak so it cannot replicate in humans and cannot cause disease.
Let me tell you that this vaccine is also modified. For this reason, the vaccine provides a code for making the coronavirus spike protein. The purpose of this process is to ensure that when the actual virus tries to infect the body, it can mount an immune response in the form of antibodies.
Sputnik uses a different vector for each of the two shots during vaccination. According to this Russian Direct Investment Fund (RDIF), the same methods are used for both shots. It provides immunity with a longer duration than other vaccines. A difference of 21 days is required for both shots.
Sputnik V (liquid) is stored at a temperature of minus 18 ° C. However, its dried form can be stored at 2–8 ° C. This does not require investing in cold-chain infrastructure. According to the RDIF, Sputnik V has been approved for the use of more than 150 crore people in 55 countries. The vaccine is proposed to be priced below $ 10 per shot. Although its price in India has not been decided.
Dr. Reddy's labs based in Hyderabad sought government approval for the vaccine in India. RDIF partnered with Dr. Reddy's in September 2020 to conduct clinical trials in the country. On Monday, the Subject Expert Committee (SEC) of the Drugs Controller General of India took the Sputnik V application for Emergency Use Authority and moved on. DCGI previously sought additional data from the drug manufacturer.
Five other Indian companies have partnered with RDIF for Sputnik V. These include Gland Pharma, Hetero Biopharma, Virchow Biotech, Panacea Biotech, and Stellis Biopharma, Bangalore-based Strides Pharma Science's bioceramic. It is expected from their partnerships that India's capacity to manufacture this vaccine will exceed 60 million.
Rakesh Sharma: 'Space travel changes the way of thinking'; Rakesh Sharma shared his old experiences
Rakesh Sharma, India's first astronaut to go to space in 1984, shared his travel experiences. He
The match between Mumbai Indians (MI) and Sunrisers Hyderabad (SRH) will be played today in the 9
American police brutality has come to the fore once again. The police brutally thrashed one of th
Controversy is increasing over the wearing of hijab by girls in schools and colleges in Karnataka
President Draupadi Murmu will address the nation on Thursday ahead of the 79th Independence Day.
Amit Shah warned Mamata on CAA Union Home Minister Amit Shah has given a big statement today rega
Prime Minister Narendra Modi on Thursday called Mukul Roy, BJP's national vice president and part
Uttar Pradesh Chief Minister Yogi Adityanath has launched a scathing attack on those who support
Karnataka Deputy CM DK Shivakumar has taken a dig at the BJP over the central government's decisi
Rising heat can scorch the country's economy, apart from life, a heatwave can also take away jobs
India can no longer ignore issues like global warming. On the one hand, where there is scorching
